Psycho-Babble Medication | about biological treatments | Framed
This thread | Show all | Post follow-up | Start new thread | List of forums | Search | FAQ

Re: wash-out before maoi King Vultan

Posted by zeugma on May 24, 2004, at 13:25:56

In reply to Re: wash-out before maoi, posted by King Vultan on May 24, 2004, at 8:03:25

> > >
> >
> > Trazodone, Serzone & Nortriptyline are all 5-HT2A & Alpha-1 NE blockers, I'd be interested to know which receptor blockade causes you grief. A Remeron trial could be revealing, it stands out from the other sedating AD's because it doesn't block Alpha-1 NE.
> >
> > Have you tried the other antihistamine for sleep like Phenergan & Polaramine? Phenergan might be bad, I think it would hit a bunch of receptors.
> >
> > Cheers,
> > Panda.
> >
> >
> >
>
> My theory is that it is these drugs' blockade of 5HT-1 receptors that is responsible. For trazodone I have a reference showing these Ki values in order of strength:
>
> alpha-1..... 12 +/- 0.2
> 5-HT2A..... 20 +/- 1
> 5-HT1A..... 29 +/- 1
> alpha-2..... 106 +/- 2
>
> Furthermore, the trazodone metabolite mCPP shows these Ki values:
>
> 5-HT1A..... 16 +/- 0.2
> alpha-1..... 97 +/- 3
> 5-HT2A..... 110 +/- 3
>
> So for the parent molecule, the 5-HT1A blockade is the 3rd most powerful--and of roughly the same order of magnitude as the alpha-1 blockade. For mCPP, the 5-HT1A blockade is by far the most powerful.
>
> So what does this mean? I'm not sure, but I bring it up because the 5-HT1A receptor seems like a strange one for an antidepressant to be blockading. After all, the presynaptic 5-HT1A receptor is the initial target and the postsynaptic 5-HT1A receptor is the ultimate target for SSRIs to stimulate. To me, it doesn't sound like a great idea to be blockading this receptor, but trazodone--and Serzone, which has a very similar pharmacology--obviously work as antidepressants for some people. My theory is that this weird 5-HT1A blockade business is one of the reasons these drugs are viewed by some as marginal antidepressants. I also think that someone like myself who reacts very strongly and quickly to an SSRI will have a greater chance of finding Serzone and trazodone to be disappointing.

The azapirones- buspirone and gepirone- are 5-HT 1A agonists, and they are even more marginal antidepressants than trazodone and the soon to be discontinued Serzone. The azapirones have even worse pharmacokinetics than trazodone and Serzone - i.e. shorter half lives, and some people claim that this is the reason they have exhibited so little success when treating depression- or anxiety, for that matter. We will see when gepirone is released in an ER formulation, but from what I have heard buspirone ER was not a notable success.

As for nortriptyline, nobody has ever claimed it is a marginal antidepressant. So maybe for a good proprtion of people its antiserotonergetic effects are therapeutic?


>
> As for nortriptyline, I don't have statistical data, but in the receptor chart in "Psychotropic Drugs", its Ki for 5-HT1 blockade, represented by ++, is higher than most of the tricyclics, and it also has only a relatively weak blockade of serotonin reuptake to counterbalance it (its most powerful effect is its blockade of NE reuptake). I found nortriptyline to have kind of a dual action, as in one way I was getting a lift, and in another I was going down in the dumps. There was enough lift, however, that there was a net antidepressant effect.
>
> None of this appears to apply to Remeron, which my book shows has zero effect on blockading 5-HT1A receptors. I'm more optimistic that this drug would have antidepressant effects for me, but I am not enthusiastic about trying it due to possible oversedation and weight gain problems.
>
> Todd

I found nortriptyline sedating enough, so I am not going near Remeron myself. The real mystery about nortriptyline is that it is the only AD with a true therapeutic window. This window cannot be based solely on its NRI effects, or adding Strattera would have resulted in loss of antidepressant effect. (?- is this reasoning off the mark? I mention it because Strattera definitely seemed to boost nortriptyline's AD effects.)

I am going to call my pdoc later and ask him to have a script called in for clomipramine. I am probably more depressed on 50 mg nortriptyline than I was on 75 mg, and sleeping worse, so i want to try the experiment of adding clomipramine and seeing if I can get a stronger AD effect from clomipramine alone than I did from nortriptyline. Then I would like to eliminate the Strattera and try a stimulant for my ADD instead.

What does your book tell you about the receptor blocking affinities of clomipramine? Probably both 5HT-1A and 5HT 2A blockade is therapeutic for me. The great experiment will be to see what 5HT reuptake inhibition does for me, since I have never taken one long enough to determine the nature of its effects. My hope is that the other actions of clomipramine will make the SRI effects tolerable.
>


Share
Tweet  

Thread

 

Post a new follow-up

Your message only Include above post


Notify the administrators

They will then review this post with the posting guidelines in mind.

To contact them about something other than this post, please use this form instead.

 

Start a new thread

 
Google
dr-bob.org www
Search options and examples
[amazon] for
in

This thread | Show all | Post follow-up | Start new thread | FAQ
Psycho-Babble Medication | Framed

poster:zeugma thread:348690
URL: http://www.dr-bob.org/babble/20040521/msgs/350166.html